Positive controls for expression modulating experiments
摘要
The invention pertains to the use of an apoptosis inducing combination of at least
a. a first expression modulating compound silencing the expression of a first target gene involved in apoptosis and
b. a second expression modulating compound silencing the expression of a second target gene involved in apoptosis
as a positive control in expression modulating assays.
申请公布号
EP2075333(A1)
申请公布日期
2009.07.01
申请号
EP20070025198
申请日期
2007.12.28
申请人
QIAGEN GMBH
发明人
HAHN, PETER, DR.;DENNIG, JOERG, DR.;BIELKE, WOLFGANG, DR.;KANG, JIE, DR.